• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

What should the C ('congestive heart failure') represent in the CHA DS -VASc score?

作者信息

Mulder Bart A, van Veldhuisen Dirk J, Rienstra Michiel

机构信息

University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

出版信息

Eur J Heart Fail. 2020 Aug;22(8):1294-1297. doi: 10.1002/ejhf.1946. Epub 2020 Jul 22.

DOI:10.1002/ejhf.1946
PMID:32592264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7539964/
Abstract
摘要

相似文献

1
What should the C ('congestive heart failure') represent in the CHA DS -VASc score?在CHA₂DS₂-VASc评分中，C（“充血性心力衰竭”）代表什么？
Eur J Heart Fail. 2020 Aug;22(8):1294-1297. doi: 10.1002/ejhf.1946. Epub 2020 Jul 22.
2
Heart failure: a weak link in CHA DS -VASc.心力衰竭：CHA2DS2-VASc 中的薄弱环节。
ESC Heart Fail. 2018 Jun;5(3):231-239. doi: 10.1002/ehf2.12262. Epub 2018 Feb 15.
3
Value of the CHA DS -VASc score for predicting outcome in patients with heart failure.CHA DS -VASc评分对预测心力衰竭患者预后的价值。
ESC Heart Fail. 2020 Oct;7(5):2553-2560. doi: 10.1002/ehf2.12831. Epub 2020 Jul 2.
4
Association of CHA DS -VASc Score with Stroke, Thromboembolism, and Death in Hip Fracture Patients.CHA2DS2-VASc 评分与髋部骨折患者的中风、血栓栓塞和死亡的关系。
J Am Geriatr Soc. 2020 Aug;68(8):1698-1705. doi: 10.1111/jgs.16452. Epub 2020 Apr 15.
5
CHA DS VASc score predicts unsuccessful electrical cardioversion in patients with persistent atrial fibrillation.CHA₂DS₂-VASc评分可预测持续性心房颤动患者电复律失败。
Intern Med J. 2017 Mar;47(3):275-279. doi: 10.1111/imj.13319.
6
Do physicians correctly calculate thromboembolic risk scores? A comparison of concordance between manual and computer-based calculation of CHADS2 and CHA2 DS2 -VASc scores.医生是否正确计算血栓栓塞风险评分？CHADS2和CHA2 DS2 -VASc评分手动计算与基于计算机计算的一致性比较。
Intern Med J. 2016 May;46(5):583-9. doi: 10.1111/imj.13048.
7
Refinement of ischemic stroke risk in patients with atrial fibrillation and CHA2 DS2 -VASc score of 1.心房颤动且CHA2 DS2 -VASc评分为1分患者缺血性中风风险的细化
Pacing Clin Electrophysiol. 2014 Nov;37(11):1442-7. doi: 10.1111/pace.12445. Epub 2014 Jul 16.
8
Baseline CHA DS -VASc score and prognosis in octogenarians with non-ST segment elevation acute coronary syndrome.80 岁以上非 ST 段抬高型急性冠状动脉综合征患者的基线 CHA2DS2-VASc 评分与预后。
Int J Clin Pract. 2021 Jun;75(6):e14082. doi: 10.1111/ijcp.14082. Epub 2021 Mar 17.
9
The prognostic value of CHA DS -VASc and modified-CHADS scores for cardiovascular events in diabetics and non-diabetics haemodialysis patients.CHA DS-VASc 和改良-CHADS 评分对糖尿病和非糖尿病血液透析患者心血管事件的预后价值。
Nephrology (Carlton). 2023 Jul;28(7):387-398. doi: 10.1111/nep.14165. Epub 2023 Apr 28.
10
CHA DS -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm.射血分数降低且为窦性心律的心力衰竭患者的CHA DS -VASc评分与不良结局
Eur J Heart Fail. 2016 Oct;18(10):1261-1266. doi: 10.1002/ejhf.613. Epub 2016 Jul 21.

引用本文的文献

1
Outcomes of patients with atrial fibrillation on oral anticoagulation with and without heart failure: the ETNA-AF-Europe registry.伴有和不伴有心力衰竭的房颤患者口服抗凝治疗的结局：ETNA-AF-Europe 注册研究。
Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad280.
2
Echocardiographic predictors of thrombus in left atrial appendage-The role of novel transthoracic parameters.经胸超声心动图预测左心耳血栓形成——新型经胸参数的作用
Front Cardiovasc Med. 2022 Nov 30;9:1059111. doi: 10.3389/fcvm.2022.1059111. eCollection 2022.
3
Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation or atrial flutter.

本文引用的文献

1
Comorbidities and cause-specific outcomes in heart failure across the ejection fraction spectrum: A blueprint for clinical trial design.射血分数范围内心力衰竭的合并症及特定病因结局：临床试验设计蓝图
Int J Cardiol. 2020 Aug 15;313:76-82. doi: 10.1016/j.ijcard.2020.04.068. Epub 2020 Apr 30.
2
Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.心房颤动对射血分数降低、中等范围或保留的心力衰竭患者的影响。
Heart. 2020 Aug;106(15):1160-1168. doi: 10.1136/heartjnl-2019-316219. Epub 2020 Apr 27.
3
Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins.
心力衰竭与房颤或房扑患者左心房血栓形成的风险。
ESC Heart Fail. 2022 Dec;9(6):4064-4076. doi: 10.1002/ehf2.14105. Epub 2022 Aug 30.
4
Usefulness of B-Type Natriuretic Peptide for Predicting the Risk of Stroke in Patients With Heart Failure With Preserved Ejection Fraction.B 型利钠肽对射血分数保留的心力衰竭患者发生卒中风险的预测价值。
J Am Heart Assoc. 2022 Aug 2;11(15):e024302. doi: 10.1161/JAHA.121.024302. Epub 2022 Jul 29.
5
Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation.射血分数保留的心力衰竭：解释心房颤动临床意义的另一种范式。
Heart Rhythm O2. 2021 Dec 17;2(6Part B):771-783. doi: 10.1016/j.hroo.2021.09.015. eCollection 2021 Dec.
6
Update on management of atrial fibrillation in heart failure: a focus on ablation.心力衰竭中心房颤动管理的最新进展：聚焦消融。
Heart. 2022 Mar;108(6):422-428. doi: 10.1136/heartjnl-2020-318081. Epub 2021 Jun 4.
射血分数保留的心力衰竭与心房颤动：罪恶双生子。
J Am Coll Cardiol. 2016 Nov 15;68(20):2217-2228. doi: 10.1016/j.jacc.2016.08.048.
4
Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48.依度沙班对比华法林在伴有心房颤动和心力衰竭患者中的疗效和安全性：来自 ENGAGE AF-TIMI 48 的观察。
Eur J Heart Fail. 2016 Sep;18(9):1153-61. doi: 10.1002/ejhf.595. Epub 2016 Jun 28.
5
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南：欧洲心脏病学会（ESC）急性和慢性心力衰竭诊断与治疗特别工作组。由ESC心力衰竭协会（HFA）特别贡献制定。
Eur J Heart Fail. 2016 Aug;18(8):891-975. doi: 10.1002/ejhf.592. Epub 2016 May 20.
6
The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation.ABC（年龄、生物标志物、临床病史）卒中风险评分：一种基于生物标志物的房颤卒中预测风险评分。
Eur Heart J. 2016 May 21;37(20):1582-90. doi: 10.1093/eurheartj/ehw054. Epub 2016 Feb 25.
7
Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes.射血分数降低与保留型心力衰竭所致心房颤动：死亡及不良结局的系统评价与荟萃分析
Int J Cardiol. 2016 Jan 15;203:660-6. doi: 10.1016/j.ijcard.2015.10.220. Epub 2015 Oct 28.
8
Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: The stroke prevention in atrial fibrillation study.心房颤动患者阿司匹林治疗期间血栓栓塞的危险因素：心房颤动卒中预防研究
J Stroke Cerebrovasc Dis. 1995;5(3):147-57. doi: 10.1016/S1052-3057(10)80166-1. Epub 2010 Jun 10.
9
Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.评估 CHA2DS2-VASc 评分在伴有和不伴有心房颤动的心力衰竭患者中预测缺血性卒、血栓栓塞和死亡的价值。
JAMA. 2015 Sep 8;314(10):1030-8. doi: 10.1001/jama.2015.10725.
10
Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure.心房颤动和心力衰竭患者左心室功能障碍程度、症状状态与栓塞事件风险的关系。
Stroke. 2015 Mar;46(3):667-72. doi: 10.1161/STROKEAHA.114.007140. Epub 2015 Jan 27.